Pharmacotherapy for obesity: are we ready to select, tailor and combine pharmacotherapy to achieve more ambitious goals?

Recent advancements in obesity pharmacotherapy have seen the approval of novel agents, like glucagon-like peptide-1 receptor agonist and dual agonists, offering unprecedented efficacy for obesity management. However, treatment outcomes remain highly variable, necessitating a more personalized approa...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Nele Steenackers, Julia Toumassian, Ellen Deleus, Ann Mertens, Matthias Lannoo, Sofia Pazmino, Amar Daniël Emanuel van Laar, Bart Van der Schueren, Roman Vangoitsenhoven
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2025-06-01
Serie:	Frontiers in Endocrinology
Soggetti:	obesity obesity pharmacotherapy precision medicine personalized treatment combination therapy weight management
Accesso online:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1569468/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!